Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates
The aim of the study is to report the rare association of two complications of long-term treatment of osteoporosis with bisphosphonates in the same Caucasian elderly patient. A female patient of Italian descent, age 87 years, consulted in February 2013. She had a history of osteoporosis and had take...
Gespeichert in:
Veröffentlicht in: | Osteoporosis international 2017-03, Vol.28 (3), p.1145-1147 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1147 |
---|---|
container_issue | 3 |
container_start_page | 1145 |
container_title | Osteoporosis international |
container_volume | 28 |
creator | Sánchez, A. Blanco, R. |
description | The aim of the study is to report the rare association of two complications of long-term treatment of osteoporosis with bisphosphonates in the same Caucasian elderly patient. A female patient of Italian descent, age 87 years, consulted in February 2013. She had a history of osteoporosis and had taken alendronate weekly for 7 years (1999–2006). Due to low back pain, an orthopedist had indicated i.v. zoledronic acid, 5 mg/year for 3 years (2006–2008). She received occasional supplements of ergocalciferol. In 2009, she suffered a fall and sustained a subtrochanteric fracture of the left femur. She was operated on and recovered uneventfully. In 2012, she consulted a dentist due to loose teeth. She underwent the removal of a molar and was given a denture. She had discomfort when using the prosthesis, and developed an ulceration in the gum of the mandible, which exposed the bone and did not heal for 2 months. After radiologic studies, the diagnosis was osteonecrosis of the jaw. She improved after surgical debridement and local and systemic antibiotics. In early 2013, laboratory tests were normal except for a slight elevation of serum PTH and CTX-I. Calcitriol 0.25 mcg/day was prescribed; after 3 months serum calcium, phosphate, PTH, and CTX-I showed no variation. Two years later, she experienced acute low back pain after a fall; MRI showed recent crushing of D12, and chronic deformities of D11 and L1. Bone densitometry of her right hip (DXA) showed a T-score of −2.3 at the femoral neck. An X-ray film of the right femur showed diffuse thickening of both cortices. She was treated with nasal calcitonin and analgesics. After the back pain subsided, she was treated with s.c. denosumab. Although the association of ONJ and AFF was known in cancer patients treated with high doses of bisphosphonates, it is very rare in patients with osteoporosis receiving these drugs at usual doses. Only three cases have been reported, all in oriental women. This appears to be the first reported case in a Caucasian woman. |
doi_str_mv | 10.1007/s00198-016-3840-z |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1842548453</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2008064243</sourcerecordid><originalsourceid>FETCH-LOGICAL-c398t-1c625835470ef0a12a70865cceaa2e9e39348c824f9c64a855de039881a8fc613</originalsourceid><addsrcrecordid>eNp1kU9rFDEYh4Modlv9AF4k4GV7GJt_k0mOpbjWUtxLBW8hzb7jZplNxiRD2X4AP7cZtioUPIQXkuf3S8iD0DtKPlJCuotMCNWqIVQ2XAnSPL5ACyo4b5iW7Uu0IJp3jRb0-wk6zXlHakbr7jU6YZ2SktFugX6tc4EYwKWYfcaxx2ULeGcf8HL99eYc27DBthxG7-yAe9jHNM9kXZkS4OXlanWOfagYjnPRGFMs3uHRFg-hYLdNMczZ4YBLAltggx982eJ7n8dtnFeom_kNetXbIcPbp3mGvq0-3V1dN7frz1-uLm8bx7UqDXWStYq3oiPQE0uZ7YiSrXNgLQMNXHOhnGKi104Kq9p2A6QmFbWqd5LyM7Q89o4p_pwgF7P32cEw2ABxyoYqwVqhRMsr-uEZuotTCvV1hhGiiBRMzBQ9UvMH5gS9GZPf23QwlJhZkjlKMlWSmSWZx5p5_9Q83e9h8zfxx0oF2BHI9Sj8gPTv6v-3_gbmO53D</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2008064243</pqid></control><display><type>article</type><title>Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Sánchez, A. ; Blanco, R.</creator><creatorcontrib>Sánchez, A. ; Blanco, R.</creatorcontrib><description>The aim of the study is to report the rare association of two complications of long-term treatment of osteoporosis with bisphosphonates in the same Caucasian elderly patient. A female patient of Italian descent, age 87 years, consulted in February 2013. She had a history of osteoporosis and had taken alendronate weekly for 7 years (1999–2006). Due to low back pain, an orthopedist had indicated i.v. zoledronic acid, 5 mg/year for 3 years (2006–2008). She received occasional supplements of ergocalciferol. In 2009, she suffered a fall and sustained a subtrochanteric fracture of the left femur. She was operated on and recovered uneventfully. In 2012, she consulted a dentist due to loose teeth. She underwent the removal of a molar and was given a denture. She had discomfort when using the prosthesis, and developed an ulceration in the gum of the mandible, which exposed the bone and did not heal for 2 months. After radiologic studies, the diagnosis was osteonecrosis of the jaw. She improved after surgical debridement and local and systemic antibiotics. In early 2013, laboratory tests were normal except for a slight elevation of serum PTH and CTX-I. Calcitriol 0.25 mcg/day was prescribed; after 3 months serum calcium, phosphate, PTH, and CTX-I showed no variation. Two years later, she experienced acute low back pain after a fall; MRI showed recent crushing of D12, and chronic deformities of D11 and L1. Bone densitometry of her right hip (DXA) showed a T-score of −2.3 at the femoral neck. An X-ray film of the right femur showed diffuse thickening of both cortices. She was treated with nasal calcitonin and analgesics. After the back pain subsided, she was treated with s.c. denosumab. Although the association of ONJ and AFF was known in cancer patients treated with high doses of bisphosphonates, it is very rare in patients with osteoporosis receiving these drugs at usual doses. Only three cases have been reported, all in oriental women. This appears to be the first reported case in a Caucasian woman.</description><identifier>ISSN: 0937-941X</identifier><identifier>EISSN: 1433-2965</identifier><identifier>DOI: 10.1007/s00198-016-3840-z</identifier><identifier>PMID: 27866217</identifier><language>eng</language><publisher>London: Springer London</publisher><subject>Aged, 80 and over ; Alendronate - administration & dosage ; Alendronate - adverse effects ; Alendronic acid ; Analgesics ; Antibiotics ; Back pain ; Bisphosphonate-Associated Osteonecrosis of the Jaw - diagnostic imaging ; Bisphosphonate-Associated Osteonecrosis of the Jaw - etiology ; Bisphosphonates ; Bone Density Conservation Agents - administration & dosage ; Bone Density Conservation Agents - adverse effects ; Calcitonin ; Calcitriol ; Calcium (blood) ; Calcium phosphates ; Cancer ; Case Report ; Collagen ; Densitometry ; Diphosphonates - administration & dosage ; Diphosphonates - adverse effects ; Drug Administration Schedule ; Drug Therapy, Combination ; Dual energy X-ray absorptiometry ; Endocrinology ; Female ; Femur ; Fractures ; Fractures, Spontaneous - chemically induced ; Fractures, Spontaneous - diagnostic imaging ; Geriatrics ; Hip ; Hip Fractures - chemically induced ; Hip Fractures - diagnostic imaging ; Humans ; Imidazoles - administration & dosage ; Imidazoles - adverse effects ; Jaw ; Low back pain ; Magnetic resonance imaging ; Mandible ; Medicine ; Medicine & Public Health ; Monoclonal antibodies ; Orthopedics ; Osteonecrosis ; Osteoporosis ; Osteoporosis, Postmenopausal - drug therapy ; Pain ; Parathyroid hormone ; Radiography ; Rheumatology ; Targeted cancer therapy ; Teeth ; Zoledronic acid</subject><ispartof>Osteoporosis international, 2017-03, Vol.28 (3), p.1145-1147</ispartof><rights>International Osteoporosis Foundation and National Osteoporosis Foundation 2016</rights><rights>Osteoporosis International is a copyright of Springer, (2016). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c398t-1c625835470ef0a12a70865cceaa2e9e39348c824f9c64a855de039881a8fc613</citedby><cites>FETCH-LOGICAL-c398t-1c625835470ef0a12a70865cceaa2e9e39348c824f9c64a855de039881a8fc613</cites><orcidid>0000-0002-0761-4385</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00198-016-3840-z$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00198-016-3840-z$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27866217$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sánchez, A.</creatorcontrib><creatorcontrib>Blanco, R.</creatorcontrib><title>Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates</title><title>Osteoporosis international</title><addtitle>Osteoporos Int</addtitle><addtitle>Osteoporos Int</addtitle><description>The aim of the study is to report the rare association of two complications of long-term treatment of osteoporosis with bisphosphonates in the same Caucasian elderly patient. A female patient of Italian descent, age 87 years, consulted in February 2013. She had a history of osteoporosis and had taken alendronate weekly for 7 years (1999–2006). Due to low back pain, an orthopedist had indicated i.v. zoledronic acid, 5 mg/year for 3 years (2006–2008). She received occasional supplements of ergocalciferol. In 2009, she suffered a fall and sustained a subtrochanteric fracture of the left femur. She was operated on and recovered uneventfully. In 2012, she consulted a dentist due to loose teeth. She underwent the removal of a molar and was given a denture. She had discomfort when using the prosthesis, and developed an ulceration in the gum of the mandible, which exposed the bone and did not heal for 2 months. After radiologic studies, the diagnosis was osteonecrosis of the jaw. She improved after surgical debridement and local and systemic antibiotics. In early 2013, laboratory tests were normal except for a slight elevation of serum PTH and CTX-I. Calcitriol 0.25 mcg/day was prescribed; after 3 months serum calcium, phosphate, PTH, and CTX-I showed no variation. Two years later, she experienced acute low back pain after a fall; MRI showed recent crushing of D12, and chronic deformities of D11 and L1. Bone densitometry of her right hip (DXA) showed a T-score of −2.3 at the femoral neck. An X-ray film of the right femur showed diffuse thickening of both cortices. She was treated with nasal calcitonin and analgesics. After the back pain subsided, she was treated with s.c. denosumab. Although the association of ONJ and AFF was known in cancer patients treated with high doses of bisphosphonates, it is very rare in patients with osteoporosis receiving these drugs at usual doses. Only three cases have been reported, all in oriental women. This appears to be the first reported case in a Caucasian woman.</description><subject>Aged, 80 and over</subject><subject>Alendronate - administration & dosage</subject><subject>Alendronate - adverse effects</subject><subject>Alendronic acid</subject><subject>Analgesics</subject><subject>Antibiotics</subject><subject>Back pain</subject><subject>Bisphosphonate-Associated Osteonecrosis of the Jaw - diagnostic imaging</subject><subject>Bisphosphonate-Associated Osteonecrosis of the Jaw - etiology</subject><subject>Bisphosphonates</subject><subject>Bone Density Conservation Agents - administration & dosage</subject><subject>Bone Density Conservation Agents - adverse effects</subject><subject>Calcitonin</subject><subject>Calcitriol</subject><subject>Calcium (blood)</subject><subject>Calcium phosphates</subject><subject>Cancer</subject><subject>Case Report</subject><subject>Collagen</subject><subject>Densitometry</subject><subject>Diphosphonates - administration & dosage</subject><subject>Diphosphonates - adverse effects</subject><subject>Drug Administration Schedule</subject><subject>Drug Therapy, Combination</subject><subject>Dual energy X-ray absorptiometry</subject><subject>Endocrinology</subject><subject>Female</subject><subject>Femur</subject><subject>Fractures</subject><subject>Fractures, Spontaneous - chemically induced</subject><subject>Fractures, Spontaneous - diagnostic imaging</subject><subject>Geriatrics</subject><subject>Hip</subject><subject>Hip Fractures - chemically induced</subject><subject>Hip Fractures - diagnostic imaging</subject><subject>Humans</subject><subject>Imidazoles - administration & dosage</subject><subject>Imidazoles - adverse effects</subject><subject>Jaw</subject><subject>Low back pain</subject><subject>Magnetic resonance imaging</subject><subject>Mandible</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Monoclonal antibodies</subject><subject>Orthopedics</subject><subject>Osteonecrosis</subject><subject>Osteoporosis</subject><subject>Osteoporosis, Postmenopausal - drug therapy</subject><subject>Pain</subject><subject>Parathyroid hormone</subject><subject>Radiography</subject><subject>Rheumatology</subject><subject>Targeted cancer therapy</subject><subject>Teeth</subject><subject>Zoledronic acid</subject><issn>0937-941X</issn><issn>1433-2965</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kU9rFDEYh4Modlv9AF4k4GV7GJt_k0mOpbjWUtxLBW8hzb7jZplNxiRD2X4AP7cZtioUPIQXkuf3S8iD0DtKPlJCuotMCNWqIVQ2XAnSPL5ACyo4b5iW7Uu0IJp3jRb0-wk6zXlHakbr7jU6YZ2SktFugX6tc4EYwKWYfcaxx2ULeGcf8HL99eYc27DBthxG7-yAe9jHNM9kXZkS4OXlanWOfagYjnPRGFMs3uHRFg-hYLdNMczZ4YBLAltggx982eJ7n8dtnFeom_kNetXbIcPbp3mGvq0-3V1dN7frz1-uLm8bx7UqDXWStYq3oiPQE0uZ7YiSrXNgLQMNXHOhnGKi104Kq9p2A6QmFbWqd5LyM7Q89o4p_pwgF7P32cEw2ABxyoYqwVqhRMsr-uEZuotTCvV1hhGiiBRMzBQ9UvMH5gS9GZPf23QwlJhZkjlKMlWSmSWZx5p5_9Q83e9h8zfxx0oF2BHI9Sj8gPTv6v-3_gbmO53D</recordid><startdate>20170301</startdate><enddate>20170301</enddate><creator>Sánchez, A.</creator><creator>Blanco, R.</creator><general>Springer London</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0761-4385</orcidid></search><sort><creationdate>20170301</creationdate><title>Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates</title><author>Sánchez, A. ; Blanco, R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c398t-1c625835470ef0a12a70865cceaa2e9e39348c824f9c64a855de039881a8fc613</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Aged, 80 and over</topic><topic>Alendronate - administration & dosage</topic><topic>Alendronate - adverse effects</topic><topic>Alendronic acid</topic><topic>Analgesics</topic><topic>Antibiotics</topic><topic>Back pain</topic><topic>Bisphosphonate-Associated Osteonecrosis of the Jaw - diagnostic imaging</topic><topic>Bisphosphonate-Associated Osteonecrosis of the Jaw - etiology</topic><topic>Bisphosphonates</topic><topic>Bone Density Conservation Agents - administration & dosage</topic><topic>Bone Density Conservation Agents - adverse effects</topic><topic>Calcitonin</topic><topic>Calcitriol</topic><topic>Calcium (blood)</topic><topic>Calcium phosphates</topic><topic>Cancer</topic><topic>Case Report</topic><topic>Collagen</topic><topic>Densitometry</topic><topic>Diphosphonates - administration & dosage</topic><topic>Diphosphonates - adverse effects</topic><topic>Drug Administration Schedule</topic><topic>Drug Therapy, Combination</topic><topic>Dual energy X-ray absorptiometry</topic><topic>Endocrinology</topic><topic>Female</topic><topic>Femur</topic><topic>Fractures</topic><topic>Fractures, Spontaneous - chemically induced</topic><topic>Fractures, Spontaneous - diagnostic imaging</topic><topic>Geriatrics</topic><topic>Hip</topic><topic>Hip Fractures - chemically induced</topic><topic>Hip Fractures - diagnostic imaging</topic><topic>Humans</topic><topic>Imidazoles - administration & dosage</topic><topic>Imidazoles - adverse effects</topic><topic>Jaw</topic><topic>Low back pain</topic><topic>Magnetic resonance imaging</topic><topic>Mandible</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Monoclonal antibodies</topic><topic>Orthopedics</topic><topic>Osteonecrosis</topic><topic>Osteoporosis</topic><topic>Osteoporosis, Postmenopausal - drug therapy</topic><topic>Pain</topic><topic>Parathyroid hormone</topic><topic>Radiography</topic><topic>Rheumatology</topic><topic>Targeted cancer therapy</topic><topic>Teeth</topic><topic>Zoledronic acid</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sánchez, A.</creatorcontrib><creatorcontrib>Blanco, R.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Osteoporosis international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sánchez, A.</au><au>Blanco, R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates</atitle><jtitle>Osteoporosis international</jtitle><stitle>Osteoporos Int</stitle><addtitle>Osteoporos Int</addtitle><date>2017-03-01</date><risdate>2017</risdate><volume>28</volume><issue>3</issue><spage>1145</spage><epage>1147</epage><pages>1145-1147</pages><issn>0937-941X</issn><eissn>1433-2965</eissn><abstract>The aim of the study is to report the rare association of two complications of long-term treatment of osteoporosis with bisphosphonates in the same Caucasian elderly patient. A female patient of Italian descent, age 87 years, consulted in February 2013. She had a history of osteoporosis and had taken alendronate weekly for 7 years (1999–2006). Due to low back pain, an orthopedist had indicated i.v. zoledronic acid, 5 mg/year for 3 years (2006–2008). She received occasional supplements of ergocalciferol. In 2009, she suffered a fall and sustained a subtrochanteric fracture of the left femur. She was operated on and recovered uneventfully. In 2012, she consulted a dentist due to loose teeth. She underwent the removal of a molar and was given a denture. She had discomfort when using the prosthesis, and developed an ulceration in the gum of the mandible, which exposed the bone and did not heal for 2 months. After radiologic studies, the diagnosis was osteonecrosis of the jaw. She improved after surgical debridement and local and systemic antibiotics. In early 2013, laboratory tests were normal except for a slight elevation of serum PTH and CTX-I. Calcitriol 0.25 mcg/day was prescribed; after 3 months serum calcium, phosphate, PTH, and CTX-I showed no variation. Two years later, she experienced acute low back pain after a fall; MRI showed recent crushing of D12, and chronic deformities of D11 and L1. Bone densitometry of her right hip (DXA) showed a T-score of −2.3 at the femoral neck. An X-ray film of the right femur showed diffuse thickening of both cortices. She was treated with nasal calcitonin and analgesics. After the back pain subsided, she was treated with s.c. denosumab. Although the association of ONJ and AFF was known in cancer patients treated with high doses of bisphosphonates, it is very rare in patients with osteoporosis receiving these drugs at usual doses. Only three cases have been reported, all in oriental women. This appears to be the first reported case in a Caucasian woman.</abstract><cop>London</cop><pub>Springer London</pub><pmid>27866217</pmid><doi>10.1007/s00198-016-3840-z</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-0761-4385</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0937-941X |
ispartof | Osteoporosis international, 2017-03, Vol.28 (3), p.1145-1147 |
issn | 0937-941X 1433-2965 |
language | eng |
recordid | cdi_proquest_miscellaneous_1842548453 |
source | MEDLINE; SpringerLink Journals |
subjects | Aged, 80 and over Alendronate - administration & dosage Alendronate - adverse effects Alendronic acid Analgesics Antibiotics Back pain Bisphosphonate-Associated Osteonecrosis of the Jaw - diagnostic imaging Bisphosphonate-Associated Osteonecrosis of the Jaw - etiology Bisphosphonates Bone Density Conservation Agents - administration & dosage Bone Density Conservation Agents - adverse effects Calcitonin Calcitriol Calcium (blood) Calcium phosphates Cancer Case Report Collagen Densitometry Diphosphonates - administration & dosage Diphosphonates - adverse effects Drug Administration Schedule Drug Therapy, Combination Dual energy X-ray absorptiometry Endocrinology Female Femur Fractures Fractures, Spontaneous - chemically induced Fractures, Spontaneous - diagnostic imaging Geriatrics Hip Hip Fractures - chemically induced Hip Fractures - diagnostic imaging Humans Imidazoles - administration & dosage Imidazoles - adverse effects Jaw Low back pain Magnetic resonance imaging Mandible Medicine Medicine & Public Health Monoclonal antibodies Orthopedics Osteonecrosis Osteoporosis Osteoporosis, Postmenopausal - drug therapy Pain Parathyroid hormone Radiography Rheumatology Targeted cancer therapy Teeth Zoledronic acid |
title | Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T06%3A59%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Osteonecrosis%20of%20the%20jaw%20(ONJ)%20and%20atypical%20femoral%20fracture%20(AFF)%20in%20an%20osteoporotic%20patient%20chronically%20treated%20with%20bisphosphonates&rft.jtitle=Osteoporosis%20international&rft.au=S%C3%A1nchez,%20A.&rft.date=2017-03-01&rft.volume=28&rft.issue=3&rft.spage=1145&rft.epage=1147&rft.pages=1145-1147&rft.issn=0937-941X&rft.eissn=1433-2965&rft_id=info:doi/10.1007/s00198-016-3840-z&rft_dat=%3Cproquest_cross%3E2008064243%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2008064243&rft_id=info:pmid/27866217&rfr_iscdi=true |